Top Markets
#1 Seeker Seeker +18.80%
#2 EXOD EXOD +9.04%
#3 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.47%
#4 Arowana Arowana +5.88%
#5 MetaDAO MetaDAO +4.67%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +4.02%
#7 Mina Protocol Mina Protocol +3.88%
#8 Pons Pons +3.00%
#9 Solstice Solstice +2.88%
#10 Official Trump Official Trump +2.75%
Coin of the day
Seeker Seeker
設定
言語
日本
通貨
USD
テーマ
Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

ALPN
株式のランク #6581
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company... Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.
株価
$64.97
最終同期: 2024-05-20
時価総額
$1.97B
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Alpine Immune Sciences, Inc. (ALPN)

カテゴリー

Healthcare
Alpine Immune Sciences, Inc.（ALPN）のEPS
March 2024 時点のEPS TTM: $-0.69
Alpine Immune Sciences, Inc.の最新の財務報告と株価によると、同社の現在のEPS（TTM）は$-0.69です。2022年末には、EPSは$-1.73で、2021年のEPS$-1.98と減少でした。
Alpine Immune Sciences, Inc.のEPS履歴（2012から2026まで）
各年末時点のEPS
年 EPS 変化
2026 (TTM) $-0.69 7.81%
2023 $-0.64 -63.01%
2022 $-1.73 -12.63%
2021 $-1.98 47.76%
2020 $-1.34 -42.24%
2019 $-2.32 -11.79%
2018 $-2.63 119.17%
2017 $-1.20 -85.22%
2016 $-8.12 -16.63%
2015 $-9.74 47.80%
2014 $-6.59 -7.18%
2013 $-7.10 69.05%
2012 $-4.20 0.00%
同様の企業または競合他社のEPS
企業 EPS EPSの差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -2,610.14%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -4,120.29%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 666.67%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 1,056.52%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH